(Q48135898)

9 February 2018

title

Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. (English)

1 reference

9 February 2018

author name string

Contarino A

1

1 reference

9 February 2018

Dellu F

2

1 reference

9 February 2018

Koob GF

3

1 reference

9 February 2018

Smith GW

4

1 reference

9 February 2018

Lee KF

5

1 reference

9 February 2018

Vale W

6

1 reference

9 February 2018

Gold LH

7

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 July 1999

1 reference

9 February 2018

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

9 February 2018

volume

835

1 reference

9 February 2018

page(s)

1-9

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

CRF and restraint-stress decrease exploratory behavior in hypophysectomized mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Dexamethasone suppresses pituitary-adrenal but not behavioral effects of centrally administered CRF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Expression cloning of a human corticotropin-releasing-factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

The effects of type I and type II corticosteroid receptor agonists on exploratory behavior and spatial memory in the Y-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Extension of a new two-trial memory task in the rat: influence of environmental context on recognition processes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

A two-trial memory task with automated recording: study in young and aged rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

ICV administration of anti-corticotropin-releasing factor antisense oligonucleotide: effects on feeding behavior and body weight.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

The use of a plus-maze to measure anxiety in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Involvement of the amygdaloid complex in neuromodulatory influences on memory storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901158-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(98)01158-5

1 reference

9 February 2018

PubMed ID

10448190

1 reference

9 February 2018